Aysegul KARALEZLİ, Emine ARGÜDER, Hatice Canan HASANOĞLU, Berker ÖZTÜRK, Habibe HEZER, Ebru Şengül PARLAK, Afra ALKAN

EVALUATION OF THE RELATIONSHIP BETWEEN HIGHDENSITY LIPOPROTEIN CHOLESTEROL LEVELS AND COMMUNITY-ACQUIRED PNEUMONIA SEVERITY IN ADULT PATIENTS

Objectives: Inflammation and acute phase reactions lead to altered high-density lipoprotein cholesterol (HDLC) concentrations. This study aimed to evaluate HDL-C levels in community-acquired pneumonia (CAP) and to determine the predictive value of disease severity in CAP. Materials and Methods: This prospective study was conducted in the Department of Pulmonary Diseases. One hundred twenty-five adult patients with CAP were included in the study. Patients were classified into three groups as follows: Group 1; outpatients, Group 2; hospitalized patients and Group 3; patients admitted to the intensive care unit. C-reactive protein (CRP), procalcitonin (PCT) and HDL-C levels were evaluated at baseline, 7th and 30th days in all CAP patients. The relationship between CRP, PCT and HDL-C levels was investigated. Diagnostic performance of baseline HDL-C levels was assessed using receiver-operating characteristic (ROC) curve analyses. Results: HDL-C levels were found to be decreased in all groups compared to their normal ranges. There was a significantly negative correlation between HDL-C and CRP and PCT (Spearman’s r=-0.557, r=-0.841, respectively; p< 0.001). The sensitivity and specificity of HDL-C cut-off value were 0.738 (95% CI=0.580-0.861) and 0.875 (95% CI=0.732-0.958), with an overall accuracy of 0.861 (95% CI=0.728-0.935). Conclusion: HDL-C levels can be used as an acute phase reactant in patients with CAP.

PDF

___

1. Heron M, Hoyert DL, Murphy SL, Xu J, Kochanek KD, Tejada-Vera B. Deaths: final data for 2006. Natl Vital Stat Rep. 2009;57(14):1–134.
2. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(2):27–72 (doi:10.1086/511159).
3. Stefan Krüger, Tobias Welte. Biomarkers in community-acquired pneumonia. Expert Rev Respir Med. 2012;6(2):203-14 (doi:10.1586/ers.12.6).
4. Saballs M, Parra S, Sahun P, et al. HDL-C levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia. Springerplus. 2016;5(1):1491 (doi:10.1186/s40064-016-3145-x).
5. Chien YF, Chen CY, Hsu CL, et al. Decreased serum level of lipoprotein cholesterol is a poor prognostic factor for patients with severe community-acquired pneumonia that required intensive care unit admission. J Crit Care. 2015;30(3):506-10 (doi:10.1016/j.jcrc.2015.01.001).
6. Parthasarathy S, Barnett J, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990;1044:275-83 (doi:10.1016/0005-2760(90)90314-n).
7. Bruckert E, Hansel B. HDL-c is a powerful lipid predictor of cardiovascular diseases. Int J Clin Pract. 2007;61(11):1905-13 (doi:10.1111/j.1742-1241.2007.01509.x).
8. Dellinger RP. The surviving sepsis campaign: Where have we been and where are we going. Cleve Clin J Med. 2015;82(4):237-44 (doi:10.3949/ccjm.82gr.15001).
9. Guo L, Ai J, Zheng Z, et al. High Density Lipoprotein Protects against polymicrobe-induced sepsis in mice. J Biol Chem. 2013;288(25):17947-53 (doi:10.1074/jbc.M112.442699).
10. Chien JY, Jerng JS, Yu CJ, Yang PC. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med. 2005;33(8):1688-93 (doi:10.1097/01.ccm.0000171183.79525.6b).
11. Yang L, Luo Z, Shi X, Pang B, Ma Y, Jin J. Different value of HDL-C in predicting outcome of ARDS secondary to bacterial and viral pneumonia: A retrospective observational study. Heart Lung. 2021;50(1):206-13 (doi:10.1016/j.hrtlng.2020.09.019)
12. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26(6):1138–80 (doi:10.1111/j.1469-0691.2011.03672.x).
13. Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2007;26(10):2170-83 (doi:10.1002/sim.2677).
14. Kaziani K, Sotiriou A, Dimopoulos G. Duration of pneumonia therapy and the role of biomarkers. Curr Opin Infect Dis. 2017;30(2):221-5 (doi:10.1097/QCO.0000000000000351).
15. Sungurlu S, Balk RA. The role of biomarkers in the diagnosis and management of pneumonia. Clin Chest Med. 2018;39(4):691–701 (doi:10.1016/j.ccm.2018.07.004).
16. Jahangiri A. High-density lipoprotein and the acute phase response. Curr Opin Endocrinol Diabetes Obes. 2010;17(2):156–60 (doi:10.1097/MED.0b013e328337278b).
17. Norata GD, Pirillo A, Ammirati E, Catapano AL. Emerging role of high density lipoproteins as a player in the immune system. Atherosclerosis. 2012;220(1):11–21 (doi:10.1016/j.atherosclerosis.2011.06.045).
18. Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169-96 (doi:10.1194/jlr.R300019-JLR200).
19. Sharifov OF, Xu X, Gaggar A, et al. Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis. PLoS One. 2013;8(5):e64486 (doi:10.1371/journal.pone.0064486).
20. Gordon EM, Figueroa DM, Barochia AV, Yao X, Levine SJ. High-density lipoproteins and apolipoprotein A-I: Potential new players in the prevention and treatment of lung disease. Front Pharmacol. 2016;7:323 (doi:10.3389/fphar.2016.00323).
21. Van Lenten BJ, Wagner AC, Nayak DP, Hama S, Navab M, Fogelman AM. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation. 2001;103(18):2283–8 (doi:10.1161/01.cir.103.18.2283).
22. Rodriguez Reguero JJ, Iglesias Cubero G, Vazquez M, et al. Variation in plasma lipid and lipoprotein concentrations in community-acquired pneumonia a six-month prospective study. Eur J Clin Cheni Clin Biochem. 1996;34(3):245-9 (doi:10.1515/cclm.1996.34.3.245).
23. Deniz O, Tozkoparan E, Yaman H, et al. Serum HDL-C levels, log (TG/HDL-C) values and serum total cholesterol/HDL-C ratios significantly correlate with radiological extent of disease in patients with community-acquired pneumonia. Clin Biochem. 2006;39(3):287-92 (doi:10.1016/j.clinbiochem.2006.01.015).
24. Gruber M, Christ-Crain M, Stolz D, et al. Prognostic impact of plasma lipids in patients with lower respiratory tract infections – an observational study. Swiss Med Wkly. 2009;139(11-12):166-72.
25. Vavrova L, Rychlikova J, Mrackova M, Navakova O, Zak A, Novak F. Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin. Clin Exp Med. 2016;16(4):557-69 (doi:10.1007/s10238-015-0390-1).